1,280
Views
8
CrossRef citations to date
0
Altmetric
State of the Art Review

Effects and safety of iron-based phosphate binders in dialysis patients: a systematic review and meta-analysis

, , , &
Pages 7-15 | Received 11 Jul 2014, Accepted 26 Sep 2014, Published online: 28 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. Bover, P. Ureña-Torres, M. J. Lloret, C. Ruiz-García, I. DaSilva, M. M. Diaz-Encarnacion, C. Mercado, S. Mateu, E. Fernández & J. Ballarin. (2016) Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opinion on Pharmacotherapy 17:9, pages 1247-1258.
Read now

Articles from other publishers (7)

José E Navarrete, Oyintayo Ajiboye & Janice I Lea. (2023) Biochemical markers of iron status and iron accumulation in peritoneal dialysis patients treated with ferric citrate. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis.
Crossref
Jeerath Phannajit, Natthaphon Wonghakaeo, Kullaya Takkavatakarn, Thanin Asawavichienjinda, Kearkiat Praditpornsilpa, Somchai Eiam-Ong & Paweena Susantitaphong. (2021) The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials. Journal of Nephrology 35:2, pages 473-491.
Crossref
Nicole M. Lioufas, Elaine M. Pascoe, Carmel M. Hawley, Grahame J. Elder, Sunil V. Badve, Geoffrey A. Block, David W. Johnson & Nigel D. Toussaint. (2022) Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD. Journal of the American Society of Nephrology 33:1, pages 59-76.
Crossref
Min Li, Xianlin Fan, Qian Mao, Qing Li, Xiujuan Zhang, Gaohong He, Shufen Zhang & Wenjun Zhang. (2021) The hollow core-shell ferric oxide entrapped chitosan microcapsules as phosphate binders for phosphorus removal in vitro. Carbohydrate Polymers 257, pages 117621.
Crossref
Anjay Rastogi, Nisha Bhatt, Sandro Rossetti & Judith Beto. (2021) Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm. Journal of Renal Nutrition 31:1, pages 21-34.
Crossref
Vivian Gasu. (2019) Phosphate binders for patients with end stage renal disease: overcoming the barriers. JBI Database of Systematic Reviews and Implementation Reports 17:1, pages 1-2.
Crossref
Xiuqin Yang, Qingning Bai, Yanguo Li, Haijun Liu, Haiying Guo & Xiaolei Zhang. (2017) Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease. Journal of Parenteral and Enteral Nutrition 42:4, pages 766-777.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.